Driven by the ongoing pace of innovation and sufficient financial support from investors, the CAR-T cell therapy market is anticipated to witness substantial growth in the foreseen future
The financial opportunity within the CAR-T cell therapy market has been analyzed across the following segments:
Target Indication(s)
Non-Hodgkins Lymphoma
Multiple Myeloma
Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Hodgkins Lymphoma
Acute Myeloid Leukemia
Ovarian Cancer
Generalized Myasthenia Gravis (MG)
Renal Cell Carcinoma
Target Antigen
CD19
BCMA
CD19/22
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Rest of the World
The Global CAR-T Cell Therapy Market (4th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:
Autolus
bluebird Bio
Bristol Myers Squibb
Carsgen Therapeutics
Cellectis
Cellular Biomedicine Group
Gilead Sciences
Innovative Cellular Therapeutics
Kuur Therapeutics
Noile-Immune Biotech
Novartis
Shanghai GeneChem
Sinobioway Cell Therapy
Takara Bio
Wellington Zhaotai Therapies
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. CAR-T Cell Therapies: Market Landscape
5. Key Insights
6. Clinical Trial ANALYSIS
7. Key Opinion Leaders
8. CAR-T Cell Therapy Profiles
9. Partnerships And Collaborations
10. Funding And Investment Analysis
11. Patent Analysis
12. Case Study: Cell Therapy Manufacturing
13. Cost Price Analysis
14. Market Forecast and Opportunity Analysis
15. Promotional Analysis
16. Company Profiles
17. Concluding Remarks
18. Executive Insights
19. Appendix 1: Tabulated Data
20. Appendix 2: List of Companies and Organizations
Get more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? |
Exploring How Artificial Intelligence Is Transforming Digital Pathology |
About Roots Analysis
Roots Analysisis a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
